Treatment of Ewing sarcoma cells with a dual inhibitor (BEZ235) of PI3K and the mechanistic target of rapamycin (mTOR), a downstream kinase in the pathway, caused extensive reprogramming of the cellular transcriptome, with thousands of genes modulated at either expression or splicing level [142]. This evidence concerns the gene MTOR and Ewing sarcoma.